Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Arthur David J.
Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rosenblum Mark J
Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lieber Jonathan I
Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director McVicar William K.
Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director McCreedy Bruce J Jr.
Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Burleson Tess
Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lammers Paul
Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HANISH ARNOLD C
Salarius Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Salarius Pharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Elvin Lee(6.09%)
Salarius Pharmaceuticals | D: Filing D
Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Salarius Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(3.8%),Lind Global Partners II LLC(3.8%), etc.
Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Salarius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
No Data